Antineoplastic AgentsCell Line, TumorDoxorubicinDrug Screening Assays, AntitumorDrug Resistance, NeoplasmApoptosisAntibiotics, AntineoplasticXenograft Model Antitumor AssaysCisplatinDrug SynergismTumor Cells, CulturedNeoplasmsImmune SystemMice, NudeCell SurvivalPaclitaxelAntineoplastic Agents, PhytogenicDrug Resistance, MultipleMice, Inbred BALB CCell ProliferationNeoplasm TransplantationEtoposideP-GlycoproteinFluorouracilDose-Response Relationship, DrugAntineoplastic Agents, AlkylatingNeoplasms, ExperimentalMice, Inbred C57BLAntineoplastic Combined Chemotherapy ProtocolsAntimetabolites, AntineoplasticDrug Delivery SystemsMice, SCIDInhibitory Concentration 50Breast NeoplasmsProto-Oncogene Proteins c-bcl-2Flow CytometryMelanoma, ExperimentalGene Expression Regulation, NeoplasticSignal TransductionTumor Suppressor Protein p53Cell CycleDaunorubicinCaspasesCamptothecinImmune ToleranceLung NeoplasmsImmunotherapyColonic NeoplasmsBlotting, WesternDNA DamageCell DivisionTransplantation, HeterologousVinblastineLeukemia P388Drug ResistanceDeoxycytidineRNA, Small InterferingTime FactorsVincristineApoptosis Regulatory ProteinsTransfectionCyclophosphamideCell DeathAntibodies, MonoclonalMitomycinCaspase 3MelanomaCell LineNeoplasm ProteinsTNF-Related Apoptosis-Inducing LigandDrug CarriersCancer VaccinesEnzyme InhibitorsT-Lymphocytesbcl-X ProteinDown-RegulationMultidrug Resistance-Associated ProteinsImmunity, InnateTumor BurdenRNA, MessengerCells, CulturedUp-RegulationOvarian NeoplasmsSarcoma 180Drug Evaluation, PreclinicalCombined Modality TherapyBleomycinGenetic TherapyDacarbazineLeukemia L1210AdenocarcinomaMembrane GlycoproteinsMitoxantroneDendritic CellsFibrosarcomaTaxoidsDisease Models, AnimalProdrugsLiver NeoplasmsReceptors, TNF-Related Apoptosis-Inducing Ligand